Clinical Trial Site

Moncton E1G 5C4

2 studies enrolling now · 2 studies all time

What they study most

Cerebral Amyloid Angiopathy, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension

Studies at this site

• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now